fda approved glp-1 receptor agonists list of and pending medications Understanding GLP-1 receptor agonists and
Description
30,31 In clinical trials, systolic BP reduction ranged from 2.8 to 4.4 mmHg

However, when used chronically or at higher doses, that slowed motility can evolve into functional paralysis of the stomach, the hallmark of gastroparesis

Lee YS, Shin S, Shigihara T, Hahm E, Liu MJ, Han J, et al

Because Saxenda slows digestion, it helps curb hunger and signal fullness to the brain

In addition to dual GLP-1R/GIPR-targeted drugs, the development of GLP-1R/GCGR dual-target drugs and GLP-1R/GIPR/GCGR triple-target drugs is a focus of ongoing multi-target GLP-1 drug development

Source NEJM To view or add a comment, sign in 2,482 followers
